These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 25190600)

  • 21. The interplay among gut microbiota, hypertension and kidney diseases: The role of short-chain fatty acids.
    Felizardo RJF; Watanabe IKM; Dardi P; Rossoni LV; Câmara NOS
    Pharmacol Res; 2019 Mar; 141():366-377. PubMed ID: 30639376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Linking gut microbiota to cardiovascular disease and hypertension: Lessons from chronic kidney disease.
    Meijers B; Jouret F; Evenepoel P
    Pharmacol Res; 2018 Jul; 133():101-107. PubMed ID: 29715498
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Gut microbiota and kidney diseases : dangerous liaisons?].
    Ghajarzadeh-Wurzner A; Berney M; Teta D; Genton L; Pruijm M
    Rev Med Suisse; 2018 Feb; 14(595):422-425. PubMed ID: 29465874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gut microbiome in chronic kidney disease: challenges and opportunities.
    Nallu A; Sharma S; Ramezani A; Muralidharan J; Raj D
    Transl Res; 2017 Jan; 179():24-37. PubMed ID: 27187743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gut microbiota and inflammation in chronic kidney disease and their roles in the development of cardiovascular disease.
    Onal EM; Afsar B; Covic A; Vaziri ND; Kanbay M
    Hypertens Res; 2019 Feb; 42(2):123-140. PubMed ID: 30504819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The crosstalk of gut microbiota and chronic kidney disease: role of inflammation, proteinuria, hypertension, and diabetes mellitus.
    Kanbay M; Onal EM; Afsar B; Dagel T; Yerlikaya A; Covic A; Vaziri ND
    Int Urol Nephrol; 2018 Aug; 50(8):1453-1466. PubMed ID: 29728993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Kidney-Gut Axis: Implications for Nutrition Care.
    Rossi M; Johnson DW; Campbell KL
    J Ren Nutr; 2015 Sep; 25(5):399-403. PubMed ID: 25812908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The gut-liver-kidney axis: Novel regulator of fatty liver associated chronic kidney disease.
    Raj D; Tomar B; Lahiri A; Mulay SR
    Pharmacol Res; 2020 Feb; 152():104617. PubMed ID: 31881272
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The gut flora modulates intestinal barrier integrity but not progression of chronic kidney disease in hyperoxaluria-related nephrocalcinosis.
    Konrad L; Andersen K; Kesper MS; Kumar SV; Mulay SR; Anders HJ
    Nephrol Dial Transplant; 2020 Jan; 35(1):86-97. PubMed ID: 31081025
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Leaky Gut and Altered Microbiome in Chronic Kidney Disease.
    Lau WL; Vaziri ND
    J Ren Nutr; 2017 Nov; 27(6):458-461. PubMed ID: 29056165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Regulation of Host Intestinal Microbiota by Polyphenols in the Development and Prevention of Chronic Kidney Disease.
    Bao N; Chen F; Dai D
    Front Immunol; 2019; 10():2981. PubMed ID: 31969882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dietary protein metabolism by gut microbiota and its consequences for chronic kidney disease patients.
    Mafra D; Barros AF; Fouque D
    Future Microbiol; 2013 Oct; 8(10):1317-23. PubMed ID: 24059921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gut hormones and gut microbiota: implications for kidney function and hypertension.
    Afsar B; Vaziri ND; Aslan G; Tarim K; Kanbay M
    J Am Soc Hypertens; 2016 Dec; 10(12):954-961. PubMed ID: 27865823
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is there interaction between gut microbial profile and cardiovascular risk in chronic kidney disease patients?
    Barros AF; Borges NA; Ferreira DC; Carmo FL; Rosado AS; Fouque D; Mafra D
    Future Microbiol; 2015; 10(4):517-26. PubMed ID: 25865191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of dietary fiber on chronic kidney disease： Base on the gut-kidney axis theory.
    Xie X; Dai S; Dai Y; Ning J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Feb; 45(2):193-197. PubMed ID: 32386047
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gut microbiota and chronic kidney disease: implications for novel mechanistic insights and therapeutic strategies.
    Pan W; Kang Y
    Int Urol Nephrol; 2018 Feb; 50(2):289-299. PubMed ID: 28849345
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The CKD bowel health study: understanding the bowel health and gastrointestinal symptom management in patients with chronic kidney disease: a mixed-methods observational longitudinal study (protocol).
    Cooper TE; Dalton A; Kieu A; Howell M; Jayanti S; Khalid R; Lim WH; Scholes-Robertson N; Craig JC; Teixeira-Pinto A; Bourke MJ; Tong A; Wong G
    BMC Nephrol; 2021 Nov; 22(1):388. PubMed ID: 34802445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resistant starch for modulation of gut microbiota: Promising adjuvant therapy for chronic kidney disease patients?
    Moraes C; Borges NA; Mafra D
    Eur J Nutr; 2016 Aug; 55(5):1813-21. PubMed ID: 26830416
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Chronic Kidney Disease - Colonic Axis.
    Pahl MV; Vaziri ND
    Semin Dial; 2015; 28(5):459-63. PubMed ID: 25855516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Link between Chronic Kidney Disease and Gut Microbiota in Immunological and Nutritional Aspects.
    Mertowska P; Mertowski S; Wojnicka J; Korona-Głowniak I; Grywalska E; Błażewicz A; Załuska W
    Nutrients; 2021 Oct; 13(10):. PubMed ID: 34684638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.